BACKGROUND: Tryptophan metabolism through the kynurenine pathway includes 2 vitamin B-6 [pyridoxal 5'-phosphate (PLP)]-dependent enzymes. We recently showed that plasma 3-hydroxykynurenine (HK) was elevated at low PLP concentrations. OBJECTIVE: We further evaluated and characterized kynurenine-based indexes as possible markers of functional B-vitamin status in plasma. DESIGN: Cross-sectional and longitudinal data were derived from the Western Norway B-vitamin Intervention Trial, including PLP, kynurenine, HK, kynurenic acid (KA), anthranilic acid, xanthurenic acid (XA), and 3-hydroxyanthranilic acid (HAA) measured in plasma at 2 time points. Partial Spearman's correlation, generalized additive models, and receiver operating characteristic (ROC) analysis were used to assess associations of kynurenines with PLP. RESULTS: Ratios HK:XA, HK:HAA, and HK:KA showed markedly stronger negative correlations with PLP than did HK alone (Spearman's ρ = -0.36, -0.29, and -0.31 compared with -0.18, respectively). All associations were nonlinear, with the strongest relation at low PLP. In the ROC analysis, areas under the curve for discriminating low PLP (less than the fifth percentile; 18.6 nmol/L) were 0.78, 0.78, and 0.74, respectively, compared with 0.65 for HK. Oral treatment with 40 mg pyridoxin hydrochloride for 28 d reduced the ratios by up to 60%, with strongest reductions for subjects with low plasma PLP at baseline. Whereas HK was associated with kidney function and several inflammatory markers, such associations were abolished or attenuated for the ratios. CONCLUSION: Plasma values of HK:XA and HK:HAA, which are substrate-product pairs for kynurenine transaminase and kynureninase, respectively, may reflect the intracellular availability of the cofactor (PLP) and, therefore, present as potential markers of functional vitamin B-6 status.
BACKGROUND:Tryptophan metabolism through the kynurenine pathway includes 2 vitamin B-6 [pyridoxal 5'-phosphate (PLP)]-dependent enzymes. We recently showed that plasma 3-hydroxykynurenine (HK) was elevated at low PLP concentrations. OBJECTIVE: We further evaluated and characterized kynurenine-based indexes as possible markers of functional B-vitamin status in plasma. DESIGN: Cross-sectional and longitudinal data were derived from the Western Norway B-vitamin Intervention Trial, including PLP, kynurenine, HK, kynurenic acid (KA), anthranilic acid, xanthurenic acid (XA), and 3-hydroxyanthranilic acid (HAA) measured in plasma at 2 time points. Partial Spearman's correlation, generalized additive models, and receiver operating characteristic (ROC) analysis were used to assess associations of kynurenines with PLP. RESULTS: Ratios HK:XA, HK:HAA, and HK:KA showed markedly stronger negative correlations with PLP than did HK alone (Spearman's ρ = -0.36, -0.29, and -0.31 compared with -0.18, respectively). All associations were nonlinear, with the strongest relation at low PLP. In the ROC analysis, areas under the curve for discriminating low PLP (less than the fifth percentile; 18.6 nmol/L) were 0.78, 0.78, and 0.74, respectively, compared with 0.65 for HK. Oral treatment with 40 mg pyridoxin hydrochloride for 28 d reduced the ratios by up to 60%, with strongest reductions for subjects with low plasma PLP at baseline. Whereas HK was associated with kidney function and several inflammatory markers, such associations were abolished or attenuated for the ratios. CONCLUSION: Plasma values of HK:XA and HK:HAA, which are substrate-product pairs for kynurenine transaminase and kynureninase, respectively, may reflect the intracellular availability of the cofactor (PLP) and, therefore, present as potential markers of functional vitamin B-6 status.
Authors: Oana M Deac; James L Mills; Barry Shane; Øivind Midttun; Per M Ueland; John T Brosnan; Margaret E Brosnan; Eamon Laird; Eileen R Gibney; Ruzong Fan; Yifan Wang; Lawrence C Brody; Anne M Molloy Journal: J Nutr Date: 2015-02-18 Impact factor: 4.798
Authors: Tonia C Carter; Faith Pangilinan; Anne M Molloy; Ruzong Fan; Yifan Wang; Barry Shane; Eileen R Gibney; Øivind Midttun; Per M Ueland; Cheryl D Cropp; Yoonhee Kim; Alexander F Wilson; Joan E Bailey-Wilson; Lawrence C Brody; James L Mills Journal: J Nutr Date: 2015-05-13 Impact factor: 4.798
Authors: Cornelia M Ulrich; Mary Playdon; Rama Kiblawi; Andreana N Holowatyj; Biljana Gigic; Stefanie Brezina; Anne J M R Geijsen; Jennifer Ose; Tengda Lin; Sheetal Hardikar; Caroline Himbert; Christy A Warby; Jürgen Böhm; Martijn J L Bours; Fränzel J B van Duijnhoven; Tanja Gumpenberger; Dieuwertje E Kok; Janna L Koole; Eline H van Roekel; Petra Schrotz-King; Arve Ulvik; Andrea Gsur; Nina Habermann; Matty P Weijenberg; Per Magne Ueland; Martin Schneider; Alexis Ulrich Journal: Br J Nutr Date: 2020-02-05 Impact factor: 3.718
Authors: Luisa Rios-Avila; Bonnie Coats; Maria Ralat; Yueh-Yun Chi; Øivind Midttun; Per M Ueland; Peter W Stacpoole; Jesse F Gregory Journal: Am J Clin Nutr Date: 2015-07-22 Impact factor: 7.045
Authors: Despoina Theofylaktopoulou; Øivind Midttun; Per M Ueland; Klaus Meyer; Anouar Fanidi; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang; Ross Prentice; Mary Pettinger; Cynthia A Thomson; Graham G Giles; Allison Hodge; Qiuyin Cai; William J Blot; Jie Wu; Mikael Johansson; Johan Hultdin; Kjell Grankvist; Victoria L Stevens; Marjorie M McCullough; Stephanie J Weinstein; Demetrius Albanes; Regina Ziegler; Neal D Freedman; Arnulf Langhammer; Kristian Hveem; Marit Naess; Howard D Sesso; J Michael Gaziano; Julie E Buring; I-Min Lee; Gianluca Severi; Xuehong Zhang; Meir J Stampfer; Jiali Han; Stephanie A Smith-Warner; Anne Zeleniuch-Jacquotte; Loic Le Marchand; Jian-Min Yuan; Renwei Wang; Lesley M Butler; Woon-Puay Koh; Yu-Tang Gao; Nathaniel Rothman; Ulrika Ericson; Emily Sonestedt; Kala Visvanathan; Miranda R Jones; Caroline Relton; Paul Brennan; Mattias Johansson; Arve Ulvik Journal: Int J Cancer Date: 2018-01-04 Impact factor: 7.396